Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus plantarum Rosell-1012 and Improved Liver Disease Biomarkers

1 of 1 paper
  • The Lactobacillus as a Probiotic: Focusing on Liver Diseases.

    • 2022-01-26
    • Review
    • Microorganisms 10(2)
      • Jin-Ju Jeong
      • Hee Jin Park
      • Min Gi Cha
      • Eunju Park
      • Sung-Min Won
      • Raja Ganesan
      • Haripriya Gupta
      • Yoseph Asmelash Gebru
      • Satya Priya Sharma
      • Su Been Lee
      • Goo Hyun Kwon
      • Min Kyo Jeong
      • Byeong Hyun Min
      • Ji Ye Hyun
      • Jung A Eom
      • Sang Jun Yoon
      • Mi Ran Choi
      • Dong Joon Kim
      • Ki Tae Suk
    • Low evidence

    They improved a wide range of diseases including liver disease, gastrointestinal diseases, respiratory diseases, and autoimmune diseases. Here, we intend to discuss in depth the genus Lactobacillus as a representative probiotic for chronic liver diseases.

    Effect
    Beneficial
    Effect size
    Moderate
Back to top